Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

INTEGRATED BIOPHARMA INC (INBP) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $1.00 Metrics
OS: 29.9 M
Market cap: $29.9 M
Net cash: $2.47 M $0.08 per share
EV: $27.5 M

 
TTM Valuation
EBITDA $2.5 M 10.9 x EV/EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsJun-30-22Jun-30-21Jun-30-20Jun-30-19Jun-30-18Jun-30-17Jun-30-16Jun-30-15
Revenues56.263.652.850.043.747.042.337.6
            Revenue growth-11.5%20.4%5.6%14.3%-6.9%10.9%12.5%11.3%
Cost of goods sold49.754.146.043.838.740.336.733.1
Gross profit6.69.56.76.25.06.75.64.5
            Gross margin11.6%14.9%12.7%12.4%11.4%14.2%13.3%12.0%
Selling, general and administrative3.83.73.53.53.33.53.43.5
EBITA2.75.83.32.71.73.22.11.1
            EBITA margin4.9%9.1%6.2%5.4%3.9%6.8%5.0%2.8%
Amortization of intangibles       0.1
EBIT2.75.83.32.71.73.22.10.9
            EBIT margin4.9%9.1%6.2%5.4%3.9%6.8%5.0%2.5%
Pre-tax income2.67.23.12.01.01.91.20.9
Income taxes-1.2-0.8-1.00.40.3-0.50.20.1
            Tax rate   17.3%32.4% 19.4%15.4%
Net income3.88.04.11.70.72.31.00.7
            Net margin6.8%12.6%7.8%3.4%1.6%5.0%2.3%2.0%
 
Diluted EPS$0.12$0.25$0.13$0.06$0.02$0.08$0.05$0.03
Shares outstanding (diluted)32.332.131.229.630.330.221.229.4
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy